Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets

被引:31
|
作者
Decaro, Nicola [1 ]
Grassi, Andrea [2 ]
Lorusso, Eleonora [1 ]
Patterson, Edward, I [3 ]
Lorusso, Alessio [4 ]
Desario, Costantina [1 ]
Anderson, Enyia R. [5 ]
Vasinioti, Violetta [1 ]
Wastika, Christida E. [5 ]
Hughes, Grant L. [5 ]
Valleriani, Fabrizia [4 ]
Colitti, Barbara [6 ]
Ricci, Dominga [7 ]
Buonavoglia, Domenico [1 ]
Rosati, Sergio [6 ]
Cavaliere, Nicola [8 ]
Paltrinieri, Saverio [9 ]
Lauzi, Stefania [9 ]
Elia, Gabriella [1 ]
Buonavoglia, Canio [1 ]
机构
[1] Univ Bari, Dept Vet Med, Valenzano, Italy
[2] I VET Srl, Lab Anal Vet, Flero, Italy
[3] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada
[4] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy
[5] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England
[6] Ambulatorio Vet Ricci Dottssa Dominga, Andria, Italy
[7] Univ Turin, Dept Vet Sci, Turin, Italy
[8] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy
[9] Univ Milan, Dept Vet Med, Lodi, Italy
基金
欧盟地平线“2020”;
关键词
cat; dog; ELISA; long-term persistence; plaque reduction neutralization test; SARS-CoV-2; antibodies; virus neutralization;
D O I
10.1111/tbed.14308
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We monitored the severe acute respiratory syndrome coronavirus 2 antibody response in seven dogs and two cats by using two multispecies ELISA tests, plaque reduction neutralisation test and virus neutralization. SARS-CoV-2 neutralizing antibodies in pets persisted up to 10 months since the first positive testing, thus replicating observations in COVID-19 human patients.
引用
收藏
页码:3073 / 3076
页数:4
相关论文
共 50 条
  • [41] Long-Term Antibody Response to SARS-CoV-2 in Children
    Gabor A. Dunay
    Madalena Barroso
    Mathias Woidy
    Marta K. Danecka
    Geraldine Engels
    Katharina Hermann
    Friederike S. Neumann
    Kevin Paul
    Jan Beime
    Gabriele Escherich
    Kristin Fehse
    Lev Grinstein
    Franziska Haniel
    Luka J. Haupt
    Laura Hecher
    Torben Kehl
    Christoph Kemen
    Markus J. Kemper
    Robin Kobbe
    Aloisa Kohl
    Thomas Klokow
    Dominik Nörz
    Jakob Olfe
    Friderike Schlenker
    Jessica Schmiesing
    Johanna Schrum
    Freya Sibbertsen
    Philippe Stock
    Stephan Tiede
    Eik Vettorazzi
    Dimitra E. Zazara
    Antonia Zapf
    Marc Lütgehetmann
    Jun Oh
    Thomas S. Mir
    Ania C. Muntau
    Søren W. Gersting
    Journal of Clinical Immunology, 2023, 43 : 46 - 56
  • [42] Long-term Outcome of Chilblains Associated with SARS-CoV-2
    Poizeau, Florence
    Barbarot, Sebastien
    Le Corre, Yannick
    Brenaut, Emilie
    Samimi, Mahtab
    Aubert, Helene
    Toubel, Alexis
    Dupuy, Alain
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [43] Long-Term Antibody Response to SARS-CoV-2 in Children
    Dunay, Gabor A.
    Barroso, Madalena
    Woidy, Mathias
    Danecka, Marta K.
    Engels, Geraldine
    Hermann, Katharina
    Neumann, Friederike S.
    Paul, Kevin
    Beime, Jan
    Escherich, Gabriele
    Fehse, Kristin
    Grinstein, Lev
    Haniel, Franziska
    Haupt, Luka J.
    Hecher, Laura
    Kehl, Torben
    Kemen, Christoph
    Kemper, Markus J.
    Kobbe, Robin
    Kohl, Aloisa
    Klokow, Thomas
    Noerz, Dominik
    Olfe, Jakob
    Schlenker, Friderike
    Schmiesing, Jessica
    Schrum, Johanna
    Sibbertsen, Freya
    Stock, Philippe
    Tiede, Stephan
    Vettorazzi, Eik
    Zazara, Dimitra E.
    Zapf, Antonia
    Luetgehetmann, Marc
    Oh, Jun
    Mir, Thomas S.
    Muntau, Ania C.
    Gersting, Soren W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (01) : 46 - 56
  • [44] Long-term neurological sequelae of SARS-CoV-2 infection
    Nature Medicine, 2022, 28 : 2269 - 2270
  • [45] Long-term neurological sequelae of SARS-CoV-2 infection
    Al-Aly, Ziyad
    NATURE MEDICINE, 2022, 28 (11) : 2269 - 2270
  • [46] Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
    Ferrari, Davide
    Di Resta, Chiara
    Tomaiuolo, Rossella
    Sabetta, Eleonora
    Pontillo, Marina
    Motta, Andrea
    Locatelli, Massimo
    VACCINE, 2021, 39 (31) : 4256 - 4260
  • [47] Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients
    F. P. Tillmann
    H. Still
    Philipp von Landenberg
    International Urology and Nephrology, 2022, 54 : 1939 - 1945
  • [48] Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients
    Tillmann, F. P.
    Still, H.
    von Landenberg, Philipp
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (08) : 1939 - 1945
  • [49] Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
    Benotmane, Ilies
    Gautier Vargas, Gabriela
    Velay, Aurelie
    Wendling, Marie-Jose
    Perrin, Peggy
    Fafi-Kremer, Samira
    Caillard, Sophie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (06) : 2307 - 2310
  • [50] Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies
    Bedini, J.
    Filella, X.
    Hidalgo, S.
    Gonzalez-Escribano, C.
    CLINICA CHIMICA ACTA, 2022, 530 : S320 - S320